Artis BioSolutions
PrivateLast Round
Seed
Apr 2, 2025
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Artis BioSolutions operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Seed round in April 2025.
Artis BioSolutions is a biotechnology company that provides integrated contract development and manufacturing organization (CDMO) services for genetic medicines and biologics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Artis BioSolutions Comparables
Compare Artis BioSolutions with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OmniaBio Inc. | 82% | |
| Andelyn Biosciences | 80% | |
| Resilience | 79% |
For institutional investors. Book with your work email.
Artis BioSolutions Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Artis BioSolutions Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oak HC/FT | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 3, 2026
Grew 744% QoQ, from 9 to 76 employees.
- Aug 26, 2026
Grew 663% QoQ from 8 to 61 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- expands_facilitiesOct 14, 2026
Artis BioSolutions opens a new genetic medicines centre of excellence in Bilbao, Spain, manufacturing synthetic DNA, mRNA active pharmaceutical ingredients, lipid nanoparticles and pharmaceutical products under GMP standards on Oct 14th '26.
- expands_facilitiesAug 26, 2026
On Aug 26th '26, Artis BioSolutions expands its facilities in Spain by launching a Genetic Medicines Center of Excellence with mRNA and lipid nanoparticle manufacturing capabilities.
For institutional investors. Book with your work email.
Artis BioSolutions Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Artis BioSolutions's valuation, stock price, and market status.
Is Artis BioSolutions a public or private company?
Artis BioSolutions is a private company.
What is the current stock price of Artis BioSolutions?
Artis BioSolutions is a private company, so its shares have no public market price. Caplight tracks Artis BioSolutions's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Artis BioSolutions worth (valuation)?
Valuation information for Artis BioSolutions is not publicly available.
Can I buy Artis BioSolutions stock?
Artis BioSolutions shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Artis BioSolutions's last funding round?
Artis BioSolutions's most recent funding round was Seed on April 2, 2025.
Who are the main investors in Artis BioSolutions?
Key investors in Artis BioSolutions include Oak HC/FT.
Will Artis BioSolutions IPO soon?
No public IPO plans have been announced for Artis BioSolutions.
How can I track Artis BioSolutions secondary market activity?
Caplight tracks bids, offers, and trades in Artis BioSolutions's shares on secondary markets.